• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . The common genetic variant rs1278960 determining expression of Interferon-lambda predicts inflammatory response in critically ill COVID-1

tetano

Editor, Senior Moderator
Sci Rep


. 2025 May 6;15(1):15802.
doi: 10.1038/s41598-025-91628-2. The common genetic variant rs1278960 determining expression of Interferon-lambda predicts inflammatory response in critically ill COVID-19 patients

Timo Mayerhöfer[SUP] 1 2 [/SUP], Michael Joannidis[SUP] 2 [/SUP], Sebastian Klein[SUP] 2 3 4 [/SUP], Andre Franke[SUP] 5 [/SUP], Sara Margarita[SUP] 6 [/SUP], Luisa Ronzoni[SUP] 6 [/SUP], Elke Pertler[SUP] 1 7 [/SUP], Sonja Wagner[SUP] 1 7 [/SUP], Sabina Sahanic[SUP] 8 [/SUP], Ivan Tancevski[SUP] 8 [/SUP], David Haschka[SUP] 8 [/SUP], Christoph Hochhold[SUP] 9 [/SUP], Benedikt Treml[SUP] 9 [/SUP], Luca Valenti[SUP] 6 10 [/SUP], Herbert Tilg[SUP] 1 [/SUP], Benedikt Schaefer[SUP] 11 [/SUP], Heinz Zoller[SUP] 1 7 [/SUP]



Affiliations
Abstract

The single nucleotide polymorphism rs12979860 is associated with the production of IFNλ4, a type III interferon, which offers protection from viral infection via its proinflammatory properties. We investigated if a genetically determined increase in IFNλ4 affects disease progression in SARS-CoV-2. This prospective, single-center study involved critically ill SARS-CoV-2 patients admitted to the intensive care unit. We performed genotyping for rs12979860 and analyzed daily laboratory data. Genotype frequencies were compared with an external validation cohort. Critically ill individuals with COVID-19 (n = 184; 29.3% women) were included. Median age was 63 years. The TT genotype was present in 11%, CT in 48% and CC in 41%. At baseline, CRP, ferritin, transferrin and neopterin did not differ significantly between groups. Longitudinal analysis revealed significant genotype-dependent differences in CRP, ferritin and neopterin with the highest peak in TT patients after 10-15 days. A higher need for renal replacement therapy (31.6% vs. 11.7%, p = 0.044) and mechanical ventilation (22 days vs. 15 days, p = 0.018) was observed in the TT group. The SNP rs12979860 near IFNL4 is associated with distinct inflammatory trajectories in critically ill COVID-19 patients. Genetic determinants of the immune response influence the severity of inflammation and clinical outcomes in severe COVID-19.

Keywords: Ferritin; IFNλ4; Immune response; Interferon lambda 4; Interleukin 28B; Neopterin; SARS-CoV-2.

 
Back
Top Bottom